Propyl gallate, a strong antioxidant, increases the ca2+ sensitivity of cardiac myofilament

Journal of Pharmacological Sciences

Volumn 109, Issue 3, 2009, Pages 456-458

  Tadano, Naoto ^a,b   Morimoto, Sachio ^a   Takahashi Yanaga, Fumi ^a   Miwa, Yoshikazu ^a   Ohtsuki, Iwao ^c   Sasaguri, Toshiyuki ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b ZENYAKU KOGYO CO LTD   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Antioxidant; Propyl gallate

Indexed keywords

ANTIOXIDANT; CALCIUM; CALCIUM SENSITIZER; CHROLOGENATE; CURCUMIN; DODECYL GALLATE; GALLIC ACID; GALLIC ACID PROPYL ESTER; PIMOBENDAN; QUERCETIN; TROLOX C; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIOXIDANT ACTIVITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; HEART MUSCLE CELL; MALE; MYOFILAMENT; NONHUMAN; RABBIT;

ANIMALS; ANTIOXIDANTS; CALCIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; MALE; MICROFILAMENTS; MYOCARDIUM; PROPYL GALLATE; RABBITS;

EID: 67249093878     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.08266SC     Document Type: Article

References (12)

1. Kass DA, Solaro RJ. Mechanisms and use of calcium-sensitizing agents in the failing heart. Circulation. 2006;113:305-315. (Pubitemid 43754389)
2. Tadano N, Morimoto S, Yoshimura A, Miura M, Yoshioka K, Sakato M, et al. SCH00013, a novel Ca2+ sensitizer with positive inotropic and no chronotropic action in heart failure. J Pharmacol Sci. 2005;97:53-60. (Pubitemid 40313099)
3. Shinke T, Shite J, Takaoka H, Hata K, Inoue N, Yoshikawa R, et al. Vitamin C restores the contractile response to dobutamine and improves myocardial efficiency in patients with heart failure after anterior myocardial infarction. Am Heart J. 2007;154:645. e641-e648. (Pubitemid 47429600)
4. Givertz MM, Sawyer DB, Colucci WS. Antioxidants and myocardial contractility: illuminating the "Dark Side" of /?- adrenergic receptor activation? Circulation. 2001;103:782-783.
5. Du CK, Morimoto S, Nishii K, Minakami R, Ohta M, Tadano N, et al. Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res. 2007;101:185-194. (Pubitemid 47196586)
6. Kaplan P, Matejovicova M, Herijgers P, Flameng W. Effect of free radical scavengers on myocardial function and Na+, K+- ATPase activity in stunned rabbit myocardium. Scand Cardio- vasc J. 2005;39:213-219. (Pubitemid 41358589)
7. Karthikeyan K, Sarala Bai BR, Gauthaman K, Niranjali Devaraj S. Protective effect of propyl gallate against myocardial oxidative stress-induced injury in rat. J Pharm Pharmacol. 2005;57: 67-73. (Pubitemid 40030104)
8. Morimoto S, Yanaga F, Minakami R, Ohtsuki I. Ca2+-sensitizing effects of the mutations at Ile-79 and Arg-92 of troponin T in hypertrophic cardiomyopathy. Am J Physiol. 1998;275:C200-C207. (Pubitemid 28381319)
9. Shirwaikar A, Rajendran K, Punitha IS. In vitro antioxidant studies on the benzyl tetra isoquinoline alkaloid berberine. Biol Pharm Bull. 2006;29:1906-1910.
10. Keith M, Geranmayegan A, Sole MJ, Kurian R, Robinson A, Omran AS, et al. Increased oxidative stress in patients with congestive heart failure. J Am Coll Cardiol. 1998;31:1352-1356. (Pubitemid 28219127)
11. Packer M, Coats AJ, Fowler MB, Katus HA, Krum H, Mohacsi P, et al. Effect of carvedilol on survival in severe chronic heart failure. N Engl J Med. 2001;344:1651-1658. (Pubitemid 32479962)
12. Anderson JL, Krause-Steinrauf H, Goldman S, Clemson BS, Domanski MJ, Hager WD, et al. Failure of benefit and early hazard of bucindolol for Class IV heart failure. J Card Fail. 2003;9:266-277. (Pubitemid 37048019)